Azione CENTRALPHL CENTRAL PHARMACEUTICALS LTD.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Central Pharmaceuticals Ltd.

Azioni

CENTRALPHL

BD0487CPL007

Prezzo di chiusura Dhaka S.E.
Altri mercati azionari
 00:00:00 04/07/2024 		Variaz. 5gg Var. 1 gen.
19,9 BDT +1,02% Grafico intraday di Central Pharmaceuticals Ltd. +6,99% -1,49%
11/03 Central Pharmaceuticals Ltd. Riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 31 dicembre 2023 CI
2023 Central Pharmaceuticals Ltd. Riporta i risultati degli utili per l'intero anno terminato il 30 giugno 2023 CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Central Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
Central Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended June 30, 2023
Central Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2022
Central Pharmaceuticals Ltd. Auditor Raises 'Going Concern' Doubt
Central Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended June 30, 2021
Central Pharmaceuticals Ltd. Reports Earnings Results for the Year Ended June 30, 2020
Central Pharmaceuticals Ltd. Restates Earnings Results for the Period from January-March 2020 and for the Period from July 2019-March 2020
Central Pharmaceuticals Ltd. Recommends 1% Cash Dividend for the Year Ended on June 30, 2019
Central Pharmaceuticals Ltd. Reports Earnings Results for the Year Ended June 30, 2019
CENTRALPHL Announces Demise of Nashima Akhter, Director on May 18, 2018
Central Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2018
Central Pharmaceuticals Ltd. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2017
Central Pharmaceuticals Ltd. Announces Unaudited Earnings Results for the First Quarter Ended September 2017
Central Pharmaceuticals Ltd. Reports Earnings Results for the Year Ended June 30, 2017
Central Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017
Central Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2016
Central Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the First Quarter Ended September 30, 2016
31,105,000 Ordinary Shares of Central Pharmaceuticals Ltd. are subject to a Lock-Up Agreement Ending on 26-JUN-2016.
16,895,000 Ordinary Shares of Central Pharmaceuticals Ltd. are subject to a Lock-Up Agreement Ending on 26-JUN-2014.
Central Pharmaceuticals Ltd. has completed an IPO in the amount of BDT 140 million.
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione CENTRALPHL
  4. Notizie Central Pharmaceuticals Ltd.
  5. Altre lingue